|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7707 USD | +0.30% |
|
+3.79% | -42.93% |
| 06-29 | Rani Therapeutics Holdings, Inc. Announces Appointment of Nicholas Maestas as Chief Financial Officer, Effective June 29, 2026 | CI |
| 06-29 | Rani Therapeutics Names Nicholas Maestas CFO | MT |
| Market Cap | 76.77M 67.08M 61.6M 57.45M 109M 7.31B 111M 742M 287M 3.58B 288M 282M 12.35B | P/E 2026 * |
-3.97x | P/E 2027 * | -3.49x |
|---|---|---|---|---|---|
| Enterprise Value | 76.77M 67.08M 61.6M 57.45M 109M 7.31B 111M 742M 287M 3.58B 288M 282M 12.35B | EV / Sales 2026 * |
18.6x | EV / Sales 2027 * | 15.6x |
| Free-Float |
78.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Rani Therapeutics Holdings, Inc.
| 1 day | +0.26% | ||
| 1 week | +3.79% | ||
| Current month | +1.32% | ||
| 1 month | -10.18% | ||
| 3 months | -8.26% | ||
| 6 months | -43.35% | ||
| Current year | -42.93% |
| 1 week | 0.72 |  | 0.82 |
| 1 month | 0.72 | | 0.92 |
| Current year | 0.68 | | 1.54 |
| 1 year | 0.39 | | 3.87 |
| 3 years | 0.39 | | 8.75 |
| 5 years | 0.39 | | 36.27 |
| 10 years | 0.39 | | 36.27 |
| Manager | Title | Age | Since |
|---|---|---|---|
Talat Imran
CEO | Chief Executive Officer | 45 | 01/06/2021 |
Nicholas Maestas
DFI | Director of Finance/CFO | 46 | 29/06/2026 |
Alireza Javadi
CTO | Chief Tech/Sci/R&D Officer | 42 | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Mir Imran
CHM | Chairman | 69 | 01/06/2021 |
Dennis Ausiello
BRD | Director/Board Member | 80 | 01/09/2018 |
Jean-Luc Butel
BRD | Director/Board Member | 69 | 06/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-03 | Free | Founder | 3,800,000 | 3.8106% | ||
| 06-03 | Free | Executive/Senior Manager | 805,500 | 0.8077% | ||
| 06-03 | Free | Chief Technology Officer | 805,500 | 0.8077% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.30% | +3.79% | +44.87% | -80.93% | 76.77M | |
| +3.98% | +10.23% | +73.54% | +132.19% | 56.21B | |
| -3.12% | +5.11% | +71.57% | +94.67% | 55.38B | |
| -8.28% | +8.04% | -10.18% | -9.81% | 23.75B | |
| +3.17% | +5.57% | +12.27% | +431.52% | 23.19B | |
| +3.64% | +10.54% | +39.81% | -4.50% | 18.14B | |
| +4.11% | +8.89% | +44.60% | -27.73% | 16.84B | |
| +2.57% | +20.26% | +181.98% | +355.99% | 15.86B | |
| +5.46% | +3.88% | +24.82% | +189.06% | 13.56B | |
| +7.20% | +10.70% | +42.91% | - | 12.97B | |
| Average | +2.78% | +6.54% | +52.62% | +120.05% | 23.6B | |
| Weighted average by Cap. | +2.17% | +6.09% | +56.77% | +134.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.13M 3.61M 3.31M 3.09M 5.86M 393M 5.95M 39.88M 15.45M 193M 15.5M 15.16M 664M | 4.92M 4.3M 3.95M 3.69M 6.99M 469M 7.1M 47.58M 18.44M 230M 18.49M 18.09M 792M |
| Net income | -33.21M -29.02M -26.65M -24.85M -47.12M -3.16B -47.91M -321M -124M -1.55B -125M -122M -5.34B | -39.93M -34.89M -32.04M -29.88M -56.64M -3.8B -57.6M -386M -149M -1.86B -150M -147M -6.42B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | $0.7707 | +0.30% | 456,832 |
| 01/07/26 | $0.7684 | +1.05% | 473,116 |
| 30/06/26 | $0.7604 | -0.56% | 213,003 |
| 29/06/26 | $0.7647 | +3.91% | 545,525 |
| 26/06/26 | $0.7359 | -0.86% | 830,349 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RANI Stock
Select your edition
All financial news and data tailored to specific country editions
